Abbonarsi

Tender to touch–Prevalence and impact of concomitant fibromyalgia and enthesitis in spondyloarthritis: An ancillary analysis of the ASAS PerSpA study - 19/11/22

Doi : 10.1016/j.jbspin.2022.105420 
Gillian E. Fitzgerald a, b, , Sinead Maguire c, d, Clementina Lopez-Medina e, f, Maxime Dougados e, Finbar D. O'Shea c, d, Nigil Haroon g, h, i, j
a School of Medicine, National University of Ireland Galway, Galway, Ireland 
b Department of Rheumatology, Galway University Hospitals, Galway, Ireland 
c School of Medicine, Trinity College Dublin, Dublin, Ireland 
d Department of Rheumatology, St. James's Hospital, Dublin, Ireland 
e University of Paris, Department of Rheumatology, Hôpital Cochin, Assistance publique–Hôpitaux de Paris, INSERM (U1153), Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, France 
f Rheumatology Department, Reina Sofia University Hospital, IMIBIC, University of Cordoba, Cordoba, Spain 
g Schroeder Arthritis Institute, University Health Network, M5T 0S8 Toronto, Ontario, Canada 
h Krembil Research Institute, University Health Network, M5T 0S8 Toronto, Ontario, Canada 
i Division of Rheumatology, Toronto Western Hospital, University Health Network, M5T 2S8 Toronto, Ontario, Canada 
j Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, M5S 1A8 Toronto, Ontario, Canada 

Corresponding author at: Department of Rheumatology, Galway University Hospitals, Galway, Ireland.Department of Rheumatology, Galway University HospitalsGalwayIreland

Highlights

Fibromyalgia is common in SpA with enthesitis, but frequently is not recognised.
Comorbid fibromyalgia increases disease severity scores in SpA with enthesitis.
Concomitant fibromyalgia and enthesitis is more common in SpA females.
Recognising fibromyalgia with enthesitis is needed to prevent overtreatment of SpA.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Objectives

The primary objective was to evaluate the co-existence of fibromyalgia (FM) & enthesitis in individuals with spondyloarthritis (SpA). Secondary objectives were to identify clinical features associated with the presence of FM in enthesitis and analyse sex-specific differences.

Methods

This was an ancillary analysis of the Assessment of SpondyloArthritis International Society Peripheral Involvement in SpA (PerSpA) study. Enthesitis was defined as the presence of enthesitis ever. Clinical FM was defined as the rheumatologist's confirmation of the presence of FM. A score of5/6 on the Fibromyalgia Rapid Screening Test (FiRST) defined a positive screening test for FM.

Results

Enthesitis ever and FM (EFM) co-existed in 10.3% (n=425) of the cohort using FiRST criteria and 5.3% using clinical diagnosis of FM. More individuals with FM by clinical diagnosis had imaging-confirmed enthesitis ever than by FiRST criteria. More females had EFM than males, defined clinically (76.9% vs 23.1%) or by FiRST criteria (62.6% vs 37.4%). Individuals with EFM had more severe disease across all measures compared to those with enthesitis only, with no significant difference between sexes. EFM was significantly associated with age, female sex, BMI, BASDAI and region.

Conclusion

FM is an important comorbidity in the setting of enthesitis in SpA. While EFM is more common in females, it is not a rare condition in males. EFM is associated with worse disease severity measures in SpA in both males and females. Recognition of FM in the setting of enthesitis is essential to prevent overtreatment and optimise patient outcomes.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Axial spondyloarthritis, Enthesitis, Fibromyalgia, Comorbidities


Mappa


© 2022  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 89 - N° 6

Articolo 105420- Novembre 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Targeted resequencing of the 13q13 spondyloarthritis-linked locus identifies a rare variant in FREM2 possibly associated with familial spondyloarthritis
  • Hendrick Mambu Mambueni, Christophe Hue, Aude Jobart-Malfait, Roula Said-Nahal, Hanane El Hafci, Hervé Petite, Christophe Nich, Maxime Breban, Félicie Costantino, Henri-Jean Garchon
| Articolo seguente Articolo seguente
  • Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab
  • Isabelle Koné-Paut, Maryam Piram, Susanne Benseler, Jasmin B. Kuemmerle-Deschner, Annette Jansson, Itzhak Rosner, Alberto Tommasini, Sara Murias, Omer Karadag, Jeremy Levy, Suzanne McCreddin, Marco Migliaccio, Fabrizio De Benedetti

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.